MyAverix Finance
US · Healthcare
Geron Corporation (GERN)
Biotechnology
Geron Corporation (GERN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GERN
Geron Corporation (GERN) — FAQ
What is GERN's P/E ratio?
The price-to-earnings (P/E) ratio for Geron Corporation (GERN) is 25.00 (data as of 2026-05-24).
Does Geron Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Geron Corporation (GERN). Check the MyAverix Finance app for the latest dividend data.
What sector is Geron Corporation in?
Geron Corporation (GERN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GERN listed on?
GERN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.